Harbor Capital Advisors’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$746K Sell
1,602
-8
-0.5% -$3.36K 0.05% 434
2026
Q1
$608K Buy
1,610
+497
+45% +$213K 0.05% 444
2025
Q4
$476K Sell
1,113
-53
-5% -$23.1K 0.04% 496
2025
Q3
$522K Sell
1,166
-2,197
-65% -$995K 0.04% 469
2025
Q2
$1.64M Buy
3,363
+35
+1% +$19.9K 0.07% 352
2025
Q1
$2.05M Buy
3,328
+140
+4% +$79.6K 0.09% 282
2024
Q4
$1.69M Buy
3,188
+496
+18% +$280K 0.07% 342
2024
Q3
$1.62M Buy
2,692
+1,451
+117% +$823K 0.07% 364
2024
Q2
$673K Buy
1,241
+925
+293% +$530K 0.05% 455
2024
Q1
$203K Buy
+316
New +$192K 0.03% 594
2023
Q3
– Sell
-37
Closed -$20K – 476
2023
Q2
$20K Buy
+37
New +$20.2K ﹤0.01% 600

Other funds holding CHE

Harbor Capital Advisors's CHE Position: Q2 2026 in Review

Harbor Capital Advisors reduced its Chemed (CHE) stake by 0.5% in Q2 2026, selling an estimated $3.36K and leaving 1,602 shares worth $746K. The position accounts for 0.05% of the portfolio, ranked #434.

Harbor Capital Advisors first reported a position in CHE in Q2 2023 and has held it in 11 quarters since. The position peaked at $2.05M in Q1 2025. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Harbor Capital Advisors held 1,602 shares of Chemed worth $746K as of Q2 2026.
  • Harbor Capital Advisors sold 8 Chemed shares in Q2 2026, an estimated $3.36K.
  • Chemed made up 0.05% of Harbor Capital Advisors's portfolio in Q2 2026, its #434 holding.
  • Harbor Capital Advisors first reported a position in Chemed in Q2 2023 and has held it in 11 quarters since.
  • Harbor Capital Advisors's Chemed position peaked at $2.05M in Q1 2025.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.